8 Coupons
-
Special Offer
-
30% off
latest life
.
.
.people
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.suven life sciences' pashamylaram facility successfully completes usfda inspection
.
.